Report - NHS England Evidence review: Rituximab for Membranous ... · treatments at 6 months (Fervenza et al 2010). Ruggenenti et al 2012 reported 65% remission in patients (n=65/100) at median

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form